17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use
Files
Publication date
2018-10
Authors
Farzan, Niloufar
Vijverberg, Susanne J.H.
Hernandez-Pacheco, N
Bel, E H D
Berce, V
Bønnelykke, K
Bisgaard, H
Burchard, E G
Canino, G
Celedón, J C
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Farzan, N, Vijverberg, S J, Hernandez-Pacheco, N, Bel, E H D, Berce, V, Bønnelykke, K, Bisgaard, H, Burchard, E G, Canino, G, Celedón, J C, Chew, F T, Chiang, W C, Cloutier, M M, Forno, E, Francis, B, Hawcutt, D B, Herrera-Luis, E, Kabesch, M, Karimi, L, Melén, E, Mukhopadhyay, S, Merid, S K, Palmer, C N, Pino-Yanes, M, Pirmohamed, M, Potočnik, U, Repnik, K, Schieck, M, Sevelsted, A, Sio, Y Y, Smyth, R L, Soares, P, Söderhäll, C, Tantisira, K G, Tavendale, R, Tse, S M, Turner, S, Verhamme, K M & Maitland-van der Zee, A-H 2018, '17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use', Allergy, vol. 73, no. 10, pp. 2083-2088. https://doi.org/10.1111/all.13499